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Abstract: Nanotechnology is an exciting field of investigation for the development of new 
treatments for many human diseases. However, it is necessary to assess the biocompatibility 
of nanoparticles in vitro and in vivo before considering clinical applications. Our character-
ization of polyol-produced maghemite γ-Fe2O3 nanoparticles showed high structural quality. 
The particles showed a homogeneous spherical size around 10 nm and could form aggregates 
depending on the dispersion conditions. Such nanoparticles were efficiently taken up in vitro 
by human endothelial cells, which represent the first biological barrier to nanoparticles in vivo. 
However, γ-Fe2O3 can cause cell death within 24 hours of exposure, most likely through oxida-
tive stress. Further in vivo exploration suggests that although γ-Fe2O3 nanoparticles are rapidly 
cleared through the urine, they can lead to toxicity in the liver, kidneys and lungs, while the 
brain and heart remain unaffected. In conclusion, γ-Fe2O3 could exhibit harmful properties and 
therefore surface coating, cellular targeting, and local exposure should be considered before 
developing clinical applications.
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Introduction
Nanomaterial structures with dimensions between 1 and 100 nm are currently used for 
medical applications; such as magnetic drug targeting, hyperthermia, and enhanced 
resolution magnetic resonance imaging.1 Nanomedicine formulations aim at improving 
distribution and accumulation at the target sites.2 Hence, nanomaterials could improve 
the therapeutic index of low molecular weight drugs and provide more effective and 
less toxic treatment.3,4 However, levels of inorganic nanoparticles (NP) have already 
increased in ambient air and have impacted public health.1,2,5
Previous studies revealed that NP, such as iron oxide NP, can enter into cells and 
accumulate in mitochondria, vesicles, phagosomes and lysosomes.6–8 It has also been 
shown that coating of NP can efficiently improve internalization in many cell types.9 
Toxic effects caused by iron oxide NP exposure remain controversial. Although the 
mechanism underlying NP-induced cytotoxicity is not completely understood, it 
could be related to inflammatory response and oxidative stress.6,10,11 While it has been 
shown that NP do not induce inflammatory reaction in vascular endothelial cells in 
vitro, they can significantly decrease cancer cell viability.7,8,12 NP activity and toxicity 
depend not only on their chemical and structural properties but also on their size and 
surface properties.13,14 For instance, cell viability is enhanced by particle hydrody-
namic size.15 However, little is known about the mechanisms involved in the potential 
adverse effects of NP, and their clinical development requires further evaluation of International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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their biocompatibility. In this general context, we examined 
the cytotoxic effects of uncoated chemically-engineered iron   
oxide NP.
Material and methods
Iron oxide NP synthesis,  
characterization and labeling
Maghemite γ-Fe2O3 NP were engineered by a two-step 
method: magnetite Fe3O4 particles were first prepared by 
the polyol method using iron acetate salt as the precur-
sor and diethyleneglycol as the solvent.16 Hot water was 
used to wash out the adsorbed organic residues on the NP 
surfaces and oxidize them to the maghemite form. The 
structure, size and shape of the particles produced were 
investigated by X-ray diffraction (PANalytical X’PertPro; 
PANalytical, Almelo, the Netherlands) and transmission 
electron microscopy (JEOL 100-CX II, 100 kV; JEOL, 
Tokyo, Japan). Their hydrodynamic mean size and sur-
face charge were determined by a dynamic light   scattering 
method (633 nm; Malvern Zetasizer; Nano, Malvern, UK) 
in deionized water, MgCl2- and CaCl2-free phosphate 
saline buffer (PBS) pH 7.2, Dulbecco’s Modified Eagle 
Medium (DMEM;   Invitrogen, Carlsbad, CA) and NaCl 
0.9% solution. γ-Fe2O3 NP were functionalized with 
3,4-dihydroxyphenylethylamine hydrochloride where the 
amine function serves to attach fluorescein isothiocyanate 
(FITC) chromophore. The functionalized γ-Fe2O3 NP 
(1 mg/mL in PBS) was mixed with 10 mg/mL of FITC 
dissolved in NaHCO3/Na2CO3 1 M overnight. Labeled 
NP were eluted with PBS and filtered through a 0.22 µm 
membrane. Labeling did not affect γ-Fe2O3 NP properties, 
as estimated by dynamic light scattering.
cell culture
Immortalized human umbilical vascular endothelial cells 
(HUVEC, Ea.hy 926 clone17) were maintained in DMEM 
plus 10% fetal bovine serum and 1% penicillin/streptomycin 
(Invitrogen).
confocal and electron microscopy
Cells were seeded on glass coverslips 24 hours prior to 
treatment with 10 µg/mL of FITC-labeled γ-Fe2O3 NP for 
indicated times. Fixed samples (4% paraformaldehyde/PBS, 
15 minutes) were mounted in 4,6-diaminidino-2-phenylindole 
(DAPI)-containing mounting medium (Vector Laboratories, 
Burlingame, CA). Images were captured using a Leica SP2 
confocal microscope (Leica Microsystems GmbH, Wetzlar, 
Germany; Imagery facility, Institut Cochin).
Cells were seeded on glass coverslips 24 hours prior to 
treatment with 10 µg/mL of γ-Fe2O3 NP for indicated times, 
then prepared for electron microscopy (3% glutaraldehyde/
PBS, 1 hour). After incubation in 1% OsO4, cells were dehy-
drated in graded dilutions of ethanol, embedded in artificial 
resin (Epon; Momentive Specialty Chemicals, Colombus, 
OH) and processed for electron microscopy. Subcellular 
localization of NP was monitored by transmission electron 
microscopy (EM10CR; Zeiss, Oberkochen, Germany; 
Imagery facility, Institut Cochin) performed at 60–80 kV on 
unstained thin sections.
Western blot
Proteins were collected in TNT buffer (10 mM Tris-
HCl pH 7.5, 150 mM NaCl, 1% Triton X100, 2 mM EDTA) 
plus protease inhibitors (Sigma-Aldrich, St Louis, MO), 
200 mM NaF and 0.1 mM Na3VO4. Equal amounts of pro-
teins (Pierce microBCA kit; Thermo Scientific, Pittsburg, 
PA) were separated with 4%–12% Nupage gels (Invitrogen) 
and transferred onto polyvinylidene fluoride (PVDF) mem-
branes (Thermo Scientific). Primary anti-phospho-Akt, Akt, 
phospho-eNOS (endothelial nitric oxide synthase), eNOS, 
and Caspase 3 antibodies were used (Cell Signaling Technol-
ogy, Beverly, MA). Alexa 680-conjugated secondary anti-
bodies (Invitrogen) were used and membranes were scanned 
using the Odyssey infrared imaging system (Li-Cor Biosci-
ences GmbH, Bad Homburg vor der Höhe, Germany).
cell viability, toxicity and intracellular 
reactive oxygen species assays
Five thousand HUVEC were cultured overnight onto 96-well 
plates. After sonication in serum-free DMEM, freshly pro-
duced γ-Fe2O3 NP were added at increasing concentrations 
at the indicated times. Cell viability was assessed using the 
3-(4,5-dimethylthiazol-2-yl)diphenyltetrazolium bromide 
(MTT) method according to manufacturer’s instructions (Sigma-
Aldrich) as previously reported.18 Cell viability was calculated 
as a ratio between treated (sample) and untreated (control).
Toxicity was measured using the lactate dehydrogenase 
(LDH) detection kit according to manufacturer’s instructions 
(Roche, Basel, Switzerland) on cell culture supernatant and 
cell lysates recovered in 2% Triton-X100. Optical density 
(OD) was measured at 492 nm with a standard microplate 
reader (Multiskan Ex; Thermo Scientific). LDH leakage 
was calculated using the following equation: [Supernatant 
OD/(Supernatant OD + Lysate OD) × 100].
Forty thousand HUVEC were cultured in 96-well 
plate format. At designated times, cells were washed and International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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incubated with Hank’s Buffered Salt Solution (HBSS) 
containing 2’,7’-dichlorofluorescin diacetate (DCFH-DA, 
20 µM, Sigma) for 30 minutes. Fluorescence was read at 
485 nm Ex/530 nm Em (Fusion). Values were normalized 
to their respective controls.
In vivo studies
Rats were cared for under the Tunisian Code of Practice for 
the Care and Use of Animals for Scientific purposes, and 
experimental protocols were approved by the Ethics Commit-
tee of the Faculte des Sciences de Bizerte (Tunisia). Wistar 
rats weighing 100–150 g (Institut Pasteur, Tunisia) were 
randomly divided into experimental and control groups. Rats 
received either γ-Fe2O3 NP (0.8 mg/kg) by single intravenous 
injection for the experimental group or saline solution (NaCl 
0.9%) for the control group. Animal weight was monitored 
during the course of the experiment. Two weeks later, rats 
were sacrificed and blood samples and organs were collected. 
For histological analysis, 4 µm-thick sections of paraffin-
embedded organs were stained with hematoxylin and eosin. 
A sample of 0.5 mL of blood was collected from each animal 
at the end of the experiment. White and red blood cells were 
counted (Medonic Blood Cell Analyzer CA 620; Medonic, 
Walpole, MA).
For clearance analysis, 0.3 mg/mL FITC-labeled 
γ-Fe2O3 NP was injected into the tail vein. Blood and 
urine were collected at the indicated times. Fluorescence 
was quantified by fluorimeter (VARIAN Cary Eclipse, 
Ex485 nm/Em500–590 nm; Agilent Technologies, Palo Alto, 
CA) and flow cytometry (FACS Coulter Epics XL, EXPO32 
software; Applied Cytometry Systems, Sacramento, CA).
statistical analysis
All experiments were carried out in triplicate and six animals 
were used per group. Data were analyzed using one-way 
analysis of variance (ANOVA) followed by unpaired Student’s 
t-test (Prism, GraphPad Software, Inc, La Jolla, CA). Values 
are expressed as mean ± standard deviation (SD). P-values 
of ,0.05 were considered statistically significant.
Results
Iron oxide NP characterization
The powder recovered by centrifugation corresponds to the 
γ-Fe2O4 phase which crystallizes in the cubic spinel structure 
(Figure 1A) with a cell parameter (a = 8.36 Å) close to that 
of bulk maghemite (a = 8.3515 Å).20 Potentiometric titration, 
using potassium permanganate solution, after dissolution of 
an appropriate amount of powder in concentrated sulfuric 
acid, established that the iron species are exclusively ferric 
ions, in agreement with the formation of the maghemite 
phase. To determine the morphology and the mean size of the 
as-produced maghemite particles, low- and high-resolution 
transmission electron microscopy was performed. Pictures 
show that γ-Fe2O3 NP were mainly uniform in size with a 
10 nm ± 20% diameter on average and with a spherical shape 
(Figure 1B). These results are in agreement with the average 
crystal size inferred from X-ray diffraction line broadening 
using the Scherrer formula.16,18 There is no evidence of physi-
cal defects such as dislocation and stacking, or of amorphous 
regions at the surface, suggesting high crystalline quality in 
single particles.
Hydrodynamic diameter and zeta potential dispersed 
in distilled water, PBS, DMEM and saline solution after 
ultrasonication are given in Table 1. The measured hydrody-
namic sizes appeared larger than when evaluated by electron 
microscopy, probably because magnetic dipole-dipole inter-
actions between 10 nm sized crystals can provoke γ-Fe2O3 
NP aggregation. This aggregation can reach micrometer-
size ranges in water, where surface charges are positive. In 
contrast, they are negative in PBS, NaCl 0.9% and DMEM. 
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Figure 1 Nanoparticles exhibit spherical shapes. A) Polyol-made iron oxide powder 
consists of maghemite nanocrystals as shown by their broadened X-ray diffraction 
pattern. B) Fe2O3 iron oxide nanoparticle morphology was observed by transmission 
electron microscopy on a collection of as-produced particles (left image). A zoom 
on one representative particle is shown (right panel).International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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These physicochemical properties might help to explain the 
potential interactions between γ-Fe2O3 NP and the biological 
environment.
Internalization of iron oxide NP
The endothelium may represent the first biological barrier to 
NP when used in vivo. We initially examined the interactions 
between human endothelial cells and γ-Fe2O3 NP by confo-
cal microscopy. FITC-labelled γ-Fe2O3 NP were incubated 
with HUVEC monolayers. This analysis clearly showed that 
γ-Fe2O3 NP could be internalized in HUVEC and most of the 
fluorescence borne by γ-Fe2O3 NP seems to localize within 
the cytoplasm (Figure 2). Electron microscopy showed that 
γ-Fe2O3 NP are found outside the cell periphery in the short 
term, but can efficiently reach internal structures within a few 
hours (Figure 3). Interestingly, aggregate features of γ-Fe2O3 
NP were observed both freely diffused in the cytoplasm and 
trapped in single membrane organelles (Figure 3). They were 
however not detected in the nucleus even after 48 hours of 
incubation. Interestingly, γ-Fe2O3 NP could penetrate cells 
without any protein-coated vesicles, suggesting a micropi-
nocytotic process.
Iron oxide NP alter endothelial viability
In order to assess biocompatibility, we investigated whether 
γ-Fe2O3 NP could alter the endothelial biology once they 
had entered the cells. We performed MTT assays that mea-
sured the mitochondrial activity and therefore reflected the 
number of viable cells. We found that γ-Fe2O3 NP had no 
significant effect on HUVEC viability up to 24 hours after 
exposure, but a severe drop-off was revealed after 48 hours 
and persisted at 72 hours (Figure 4A). Strikingly, no dose 
effects were detected, even at concentrations as low as 
0.1 mg/mL. We checked these results by measuring the cell 
toxicity of γ-Fe2O3 NP. Cell death was monitored by the 
Table 1 Physical properties of iron oxide nanoparticle
Solution ,DDLS. 
(nm)
Zeta 
potential 
(mv)
Conductivity 
(ms/cm)
Effective 
voltage 
(V)
Distilled 
water
2420 +12.8 – –
PBs  
solution
204 -23.6 15.7 49.5
DMeM 90 -9.1 14.3 49.5
saline  
solution
198 -23.3 8.7 48.6
Notes: Average hydrodynamic diameter (DLs), zeta potential, electric conductivity 
and voltage of produced iron oxide particles were measured when dispersed in 
distilled water, PBs and DMeM liquids.
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Figure 2 Nanoparticle internalization in human endothelial cells. A and B) Human 
umbilical  vein  endothelial  cells  (HUVec)  were  incubated  with  FITc-labelled 
nanoparticle (NP, 10 µg/mL, green) for the indicated times in serum-free medium. 
Nuclei were counterstained with 4,6-diamidino-2-phenylindole (DAPI) (blue) and 
samples were analyzed by confocal microscopy.
so-called LDH leakage assay. This stable cytosolic enzyme 
can leak into the extracellular fluid after membrane damage 
occurring during necrosis. Toxicity markedly increased after 
24 hours of contact with γ-Fe2O3 NP (Figure 4B), corrobo-
rating the results obtained with MTT. Furthermore, phos-
phorylation of Akt, a pro-survival protein was decreased on 
γ-Fe2O3 NP exposure, while caspase 3 cleavage, a sign of International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
Dovepress 
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Figure 3 subcellular localization of nanoparticles. Transmission electron microscopy 
was performed on human umbilical vascular endothelial cells (HUVec) exposed to 
nanoparticles for the indicated times.
apoptosis, was not observed (Figure 4C). Hence, our results 
suggest that γ-Fe2O3 NP can induce long-term toxicity in 
human endothelial cells by a necrotic process. Interest-
ingly, endothelial nitric oxide synthase (eNOS) seems to be 
transiently phosphorylated in cells exposed to γ-Fe2O3 NP 
(Figure 4C). To further evaluate whether eNOS activation 
was accompanied by an increase in oxidative stress, reac-
tive oxygen species (ROS) production was monitored. As 
shown in Figure 4D, relative ROS quantity was slightly but 
significantly enhanced in γ-Fe2O3 NP-stimulated HUVEC 
after 24 hours. Thus, cell death and ROS production both 
peak at 24 hours postexposure to γ-Fe2O3 NP. Our results 
suggest that γ-Fe2O3 NP can promote cell death after 
24 hours of exposure, most likely through oxidative stress 
and necrosis mechanisms.
In vivo toxicity of iron oxide NP
Because in vitro toxicity was observed after 24 hours, 
we decided to explore the effects of γ-Fe2O3 NP exposure 
in vivo. Clearance of injected FITC-labeled γ-Fe2O3 NP 
was estimated, compared to background fluorescence in 
controls (Figure 5A). Blood analysis showed that 40% of 
injected γ-Fe2O3 NP were removed from systemic circu-
lation after 24 hours and that 75% were eliminated after 
72 hours (Figure 5A and B). A large quantity was cleared in 
the urine (Figure 5A and B). Animal weight was monitored 
during the course of the experiments. The graph presented 
in Figure 5C illustrates the fact that γ-Fe2O3 NP did not 
alter the general health of the animals. In addition, no 
signs of distress, such as loss of hair or behavioral changes 
were observed. However, the number of white blood cells 
was augmented by about 50% in γ-Fe2O3 NP-injected 
animals, while red blood cell counts remained unaffected 
(Figure 5D). This prompted us to investigate the histology 
of the main organs for any sign of immunological reactions. 
Inflammation as indicated by eosin-positive infiltrated 
cells was detected in lungs, liver and kidney (Figure 4E, 
squares). Heart and brain structures do not appear to be 
modified in NP-injected animals.
We concluded that γ-Fe2O3 NP are efficiently taken up 
by endothelial cells where they produce toxic effects after 
24 hours. When injected in vivo, such NP can promote cel-
lular damage in the liver, kidney and lungs, although they are 
rapidly cleared. Clinical applications require improvement 
of NP biocompatibility.
Discussion
Our work was designed to determine whether 10 nm-sized 
iron oxide NP (γ-Fe2O3 NP) are biocompatible with clini-
cal use, especially local hyperthermia application in solid 
tumors. We first aimed at understanding whether γ-Fe2O3 
NP could penetrate the endothelium without causing any 
potential toxicity, using in vitro human endothelial cells 
(HUVEC) and an in vivo rat model. We found that γ-Fe2O3 
NP are internalized in HUVEC quite efficiently within a few 
hours, but can provoke cell death 24 hours postexposure, 
most likely through the oxidative stress pathway. Although 
γ-Fe2O3 NP are eliminated through urine when injected in 
vivo, they could induce toxicity in some organs while spar-
ing the brain and heart. Our study suggests that γ-Fe2O3 NP 
could be used in vivo for very short times but they may need 
further improvement to reduce their toxicity and to increase 
their targeted delivery.
Particles used here correspond to the maghemite phase 
and are free from any coating. DLS measurements have 
shown that the particles tend to aggregate when dispersed in 
hydrophilic solutions. This was also confirmed by electron 
microscopy analysis. This property may affect their biologi-
cal action; for example, increased toxicity was correlated 
with carbon nanotube aggregation.19 In addition, it has been 
suggested that cellular uptake may be modulated by aggrega-
tion state.3 Experiments demonstrated that γ-Fe2O3 NP are 
internalized either in the cytosol or in membrane-delimited 
vesicles.
Evaluation of cell toxicity by different means suggest 
a long-term toxic effect of γ-Fe2O3 NP in human endothe-
lial cells. No dose-dependent action of γ-Fe2O3 NP was 
detected. Our results point to a correlation between exposure 
time and cell toxicity. Molecular mechanisms involved in International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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γ-Fe2O3 NP-mediated cell death may rely on oxidative stress 
occurring after 24 hours. NP-decreased cell viability kinetics 
are significantly slower than canonical death inducers, such 
as staurosporine. The mechanism involved here is rather 
complex, as it requires NP entrance and interference with 
oxidative stress pathways.
To examine in vivo effects, γ-Fe2O3 NP were admin-
istered by single intravenous injection to allow maximum 
bioavailability. Their persistence and their proportional 
distribution depend on their size.3 Aggregation of particles, 
evidenced by DLS measurement in saline solution, may 
decrease when in the blood stream, because of its molecu-
lar and cellular composition and viscosity, suggesting 
that smaller clusters could form and cross the endothelial 
barrier. This was confirmed by in vitro experiments. Iron 
oxide NP led to cytopathological effects in lungs, liver and 
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kidneys following systemic administration. The perivas-
cular inflammation indicates that γ-Fe2O3 NP could reach 
several organs such as the lungs and kidneys. Correlating 
with this, we also found an increase in white blood cell 
numbers, suggesting an inflammatory process. In contrast, 
the red blood cell number remained unchanged, indicat-
ing low toxicity of these particles towards erythrocytes. 
The brain may be protected by the blood–brain barrier, 
which is selective to particles larger than 1 nm. We did not 
observe any toxicity of γ-Fe2O3 NP when applied in vitro 
to human brain endothelial cells. Absorption of γ-Fe2O3 
NP in lungs, liver and kidneys may be most likely related 
to their specific vascularization and vessel permeability. 
Our data suggest that despite rapid clearance, polyol-made 
maghemite 10 nm diameter particles induced in vitro and 
in vivo cytotoxicity after prolonged exposure. γ-Fe2O3 NP International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
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could induce adverse effects and therefore surface coating, 
cellular targeting, and local exposure should be considered 
before clinical applications are developed.
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